Clinical Trials Browser

Phase 3 × Not yet recruiting × pomalidomide × Clear all

NCT06742138 2024-12-19

To Evaluate the Efficacy and Safety of QL2109 and DARZALEX FASPRO® in Multiple Myeloma

Phase 3 Not yet recruiting

Multiple Myeloma